Senator Kennedy, Meet Avant

Share   Tweet  ADD TO STUMBLEUPON  ADD TO DEL.ICIO.US Save  Print Print   Email This Post Email This Post  

 

Vaccine developer Avant Immunotherapeutics released Phase 2 data today showing that their brain cancer vaccine may double a patient’s survival period. 10,000 Americans, including Senator Edward Kennedy, suffer from the type of cancer the vaccine targets.

More Popular Stories:






Subscribe

Leave a Reply